ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.80
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
63,279.70
-0.72%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XOMA Corporation (XOMA)

  7. XOMA Corporation (XOMA) News

XOMA XOMA Corporation

25.41
0.05 (0.20%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
XOMA Corporation XOMA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.05 0.20% 25.41 16:30:00
Open Price Low Price High Price Close Price Previous Close
25.08 25.08 25.4972 25.41 25.36
more quote information »

Recent News

Date Time Source Heading
4/25/202406:30GLOBEXOMA Earns $9 Million Milestone as FDA Grants Accelerated..
4/24/202408:00PRNUSActym Therapeutics Appoints Thomas Smart as CEO
4/03/202408:00GLOBEXOMA Corporation Announces Closing of Tender Offer
3/21/202406:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
3/19/202415:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
3/08/202406:30GLOBEXOMA Reports Fourth Quarter and Full Year 2023 Financial..
2/28/202406:30GLOBEXOMA to Present at Upcoming Investor Conferences in March
2/16/202407:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
1/18/202407:30GLOBEXOMA Expands its Commercial Royalty and Milestone Portfolio..
1/11/202415:50DJNXoma to Make $1 Million Milestone Payment to LadRx After FDA..
1/11/202415:05GLOBEFDA Acceptance of Zevra’s Arimoclomol NDA Filing for..
1/08/202406:30GLOBEXOMA Names Owen Hughes as Chief Executive Officer and..
1/02/202406:30GLOBEXOMA Announces Stock Repurchase Program of up to $50 Million
12/20/202306:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
12/19/202306:30GLOBEXOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse..
11/07/202306:30GLOBEXOMA Reports Third Quarter 2023 Financial Results and..
10/31/202306:30GLOBEXOMA Earns $5 Million Milestone Upon FDA Acceptance of Day..
9/25/202306:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
9/06/202306:30GLOBEXOMA to Present at H.C. Wainwright 25th Annual Global..
8/08/202306:30GLOBEXOMA Reports Second Quarter 2023 Financial Results and..
6/23/202317:14GLOBEXOMA Added to the Russell 2000® and Russell 3000® Indexes
6/22/202306:30GLOBEXOMA Acquires Royalty and Milestone Economics to Phase 3..
6/20/202306:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
5/09/202306:30GLOBEXOMA Reports First Quarter 2023 Financial Results and..

Your Recent History

NASDAQ
XOMA
XOMA
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved